首页> 外文期刊>Assay and drug development technologies >Geschwindner S, Dekker N, Horsefield R, Tigerstr?m A, Johansson P, Scott CW, Albert JS: Development of a plate-based optical biosensor fragment screening methodology to identify phophodiesterase 10A inhibitors. J Med Chem 2013;56:3228-3234: Commentary
【24h】

Geschwindner S, Dekker N, Horsefield R, Tigerstr?m A, Johansson P, Scott CW, Albert JS: Development of a plate-based optical biosensor fragment screening methodology to identify phophodiesterase 10A inhibitors. J Med Chem 2013;56:3228-3234: Commentary

机译:Geschwindner S,Dekker N,Horsfield R,Tigerstr?A,Johansson P,Scott CW,Albert JS:开发了一种基于板的光学生物传感器片段筛选方法,用于鉴定磷酸二酯酶10A抑制剂。 J Med Chem 2013; 56:3228-3234:评论

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The Src homology phosphotyrosyl phosphatase 2 (SHP2) is a positive effector of receptor tyrosine kinases (RTK) signaling. Furthermore, SHP2 is known to promote cell migration and invasiveness, key steps in cancer metastasis. To date, however, the mechanism by which SHP2 regulates cell movement is not fully understood. In the current report, a new role for SHP2 in regulating cell migration has been suggested. We show that SHP2 mediates lamellipodia persistence and cell polarity to promote directional cell migration in the MDA-MB231 and the MDA-MB468 basal-like and triple-negative breast cancer cell lines. We further show that SHP2 modulates the activity of focal adhesion kinase (FAK) by dephosphorylating pTyr397, the autophosphorylation site that primes FAK function. Because hyperactivation of FAK is known to counter the maturation of nascent focal complexes to focal adhesions, we propose that one of the mechanisms by which SHP2 promotes lamellipodia persistence is by downregulating FAK activity through dephosphorylation of pTyr397. The finding that inhibition of FAK activity partially restores EGF-induced lamellipodia persistence and cell migration in SHP2-silenced cells supports our proposition that SHP2 promotes growth factor - induced cell movement by acting, at least in part, on FAK. However, the effect of SHP2 inhibition in nonstimulated cells seems FAK independent as there was no significant difference between the control and the SHP2-silenced cells in pY397-FAK levels. Also, FAK inhibition did not rescue Golgi orientation defects in SHP2-silenced cells, suggesting that SHP2 acts through other mechanisms to promote cell polarity.
机译:Src同源性磷酸酪氨酰磷酸酶2(SHP2)是受体酪氨酸激酶(RTK)信号传导的正效应子。此外,已知SHP2可促进细胞迁移和侵袭性,这是癌症转移的关键步骤。然而,迄今为止,尚未完全了解SHP2调节细胞运动的机制。在本报告中,已提出SHP2在调节细胞迁移中的新作用。我们显示SHP2介导lamellipodia持久性和细胞极性,以促进MDA-MB231和MDA-MB468基底样和三阴性乳腺癌细胞系中的定向细胞迁移。我们进一步表明,SHP2通过对pTyr397(引发FAK功能的自磷酸化位点)进行去磷酸化来调节粘着斑激酶(FAK)的活性。因为已知FAK的过度激活可抵抗新生的局灶复合物向局灶性粘膜的成熟,所以我们提出SHP2促进层状脂蛋白持久性的机制之一是通过pTyr397的去磷酸化来下调FAK活性。抑制FAK活性可以部分恢复EGF诱导的SHP2沉默细胞的片状脂蛋白持久性和细胞迁移的发现,支持了我们的主张,即SHP2通过至少部分作用于FAK来促进生长因子诱导的细胞运动。但是,SHP2抑制在非刺激细胞中的作用似乎与FAK无关,因为在对照和SHP2沉默的细胞之间,pY397-FAK水平没有显着差异。同样,FAK抑制不能挽救SHP2沉默细胞中的高尔基体定向缺陷,表明SHP2通过其他机制促进细胞极性。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号